Lv5
840 积分 2022-06-24 加入
TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WITH RO7790121 DEMONSTRATES EARLY CLINICAL RESPONSE AND SYMPTOM IMPROVEMENT – RESULTS FROM THE PHASE 2B TUSCANY-2 TRIAL
8天前
已关闭
Induction of interferon in mice by 10-carboxymethyl-9-acridanone
9天前
已完结
支气管哮喘防治指南（2024年版）
1个月前
已完结
The TL1A inhibitors in IBD: what’s in the pot?
1个月前
已完结
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
1个月前
已完结
Chapter Ten - TL1A: A model for a precision medicine approach in the treatment of Crohn’s disease and ulcerative colitis
1个月前
已关闭
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
2个月前
已完结
Biotechs step on cGAS for autoimmune diseases
3个月前
已完结
Exploring cGAS-STING Pathway in Sjögren’s Disease: Driver of IFN production and Potential Therapeutic Target
3个月前
已关闭
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies
3个月前
已完结
Hypobaric Unilateral Spinal Anesthesia Versus General Anesthesia for Hip Fracture Surgery in the Elderly: A Randomized Controlled Trial
2年前
已采纳
Future of genetic therapies for rare genetic diseases: what to expect for the next 15 years?
2年前
已采纳
A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
2年前
已采纳
Functional characterization of the long noncoding RNA MIR22HG as a tumour suppressor in cervical cancer by targeting IGF2BP2
2年前
已采纳
皖公网安备34019202002308
